tiprankstipranks
Trending News
More News >
Clinical Laserthermia Systems AB Class B (SE:CLS.B)
:CLS.B
Sweden Market

Clinical Laserthermia Systems AB Class B (CLS.B) Financial Statements

Compare
0 Followers

Clinical Laserthermia Systems AB Class B Financial Overview

Clinical Laserthermia Systems AB Class B's market cap is currently kr57.17M. The company's EPS TTM is kr-3.057; its P/E ratio is ―; Clinical Laserthermia Systems AB Class B is scheduled to report earnings on ―, and the estimated EPS forecast is kr―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenuekr 18.78Mkr 8.27Mkr 6.27Mkr 2.25Mkr 1.33M
Gross Profitkr 10.42Mkr 3.00Mkr -2.79Mkr -3.63Mkr 876.00K
Operating Incomekr -54.25Mkr -65.93Mkr -67.44Mkr -60.68Mkr -51.81M
EBITDAkr -44.76Mkr -68.41Mkr -57.84Mkr -57.05Mkr -51.61M
Net Incomekr -47.62Mkr -79.79Mkr -70.66Mkr -63.62Mkr -57.94M
Balance Sheet
Cash & Short-Term Investmentskr 22.51Mkr 15.33Mkr 10.59Mkr 31.17Mkr 11.87M
Total Assetskr 78.56Mkr 57.73Mkr 49.51Mkr 66.74Mkr 44.40M
Total Debtkr 224.00Kkr 454.00Kkr 30.68Mkr 273.50Kkr 673.50K
Net Debtkr -22.28Mkr -14.88Mkr 20.23Mkr -1.43Mkr 78.83K
Total Liabilitieskr 12.88Mkr 14.20Mkr 41.64Mkr 45.55Mkr 30.47M
Stockholders' Equitykr 68.72Mkr 45.77Mkr 9.22Mkr 21.79Mkr 13.93M
Cash Flow
Free Cash Flowkr -63.92Mkr -71.95Mkr -71.25Mkr -66.73Mkr -55.76M
Operating Cash Flowkr 0.00kr -66.45Mkr -70.69Mkr -66.17Mkr -55.41M
Investing Cash Flowkr -7.47Mkr -5.50Mkr -886.00Kkr -408.00Kkr -508.00K
Financing Cash Flowkr 71.10Mkr 76.69Mkr 61.84Mkr 85.88Mkr 62.02M
Currency in SEK

Clinical Laserthermia Systems AB Class B Earnings and Revenue History

Clinical Laserthermia Systems AB Class B Debt to Assets

Clinical Laserthermia Systems AB Class B Cash Flow

Clinical Laserthermia Systems AB Class B Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis